New drug BW-50218 tested in healthy volunteers for safety
NCT ID NCT07577479
First seen May 17, 2026 · Last updated May 19, 2026 · Updated 1 time
Summary
This early-phase study tests a single dose of BW-50218 in 24 healthy Chinese adults to see if it is safe and how the body processes it. Participants will be monitored for side effects and changes in blood tests, vital signs, and heart activity for up to a year. The goal is to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Argo Investigative Site
Shanghai, China
Conditions
Explore the condition pages connected to this study.